|
Pyrimidine Ribonucleotides Interconversion
|
2.58
|
0.0444
|
NME4,SMARCAL1
|
|
Pyrimidine Ribonucleotides De Novo Biosynthesis
|
2.55
|
0.0426
|
NME4,SMARCAL1
|
|
Salvage Pathways of Pyrimidine Ribonucleotides
|
1.95
|
0.0211
|
NME4,POMK
|
|
Pyrimidine Deoxyribonucleotides De Novo Biosynthesis I
|
1.42
|
0.0435
|
NME4
|
|
Nucleotide Excision Repair Pathway
|
1.24
|
0.0286
|
POLR2B
|
|
Assembly of RNA Polymerase II Complex
|
1.09
|
0.02
|
POLR2B
|
|
Pyridoxal 5′-phosphate Salvage Pathway
|
0.983
|
0.0154
|
POMK
|
|
Mitotic Roles of Polo-Like Kinase
|
0.977
|
0.0152
|
ANAPC5
|
|
Protein Kinase A Signaling
|
0.836
|
0.005
|
PTPN14,ANAPC5
|
|
Androgen Signaling
|
0.767
|
0.00901
|
POLR2B
|
|
p38 MAPK Signaling
|
0.736
|
0.00833
|
MKNK1
|
|
RhoA Signaling
|
0.723
|
0.00806
|
RAPGEF6
|
|
Estrogen Receptor Signaling
|
0.711
|
0.00781
|
POLR2B
|
|
Hereditary Breast Cancer Signaling
|
0.665
|
0.00694
|
POLR2B
|
|
IL-12 Signaling and Production in Macrophages
|
0.66
|
0.00685
|
REL
|
|
Regulation of eIF4 and p70S6K Signaling
|
0.632
|
0.00637
|
MKNK1
|
|
CREB Signaling in Neurons
|
0.568
|
0.00538
|
POLR2B
|
|
RAR Activation
|
0.56
|
0.00526
|
REL
|
|
ERK/MAPK Signaling
|
0.541
|
0.005
|
MKNK1
|
|
Systemic Lupus Erythematosus Signaling
|
0.499
|
0.00444
|
SNRNP200
|
|
Huntington’s Disease Signaling
|
0.461
|
0.004
|
POLR2B
|
|
Protein Ubiquitination Pathway
|
0.441
|
0.00377
|
ANAPC5
|
|
Glucocorticoid Receptor Signaling
|
0.358
|
0.00295
|
POLR2B
|
|
Axonal Guidance Signaling
|
0.27
|
0.00221
|
MKNK1
|
